1.
Vranic S, Basu GD, Hall DW, Gatalica Z. Tumor-Type Agnostic, Targeted Therapies: BRAF Inhibitors Join the Group. ama [Internet]. 2023Mar.21 [cited 2024May4];51(3):217-31. Available from: https://www.ama.ba/index.php/ama/article/view/508